Piramal is a global leader in delivering customer-centric solutions in the field of Antibody Drug Conjugates (ADCs) to global pharmaceutical companies. Our world-class facilities in the UK and US, backed by a highly experienced team, offer integrated services from Conjugation Development to Clinical and Commercial ADC GMP batch manufacturing and Fill/Finish.

We offer end-to-end service from conjugation development through clinical trials supply to commercial manufacture. Through our world-class facilities we offer a seamless solution for our clients' ADC projects. With short lead times to access our services and a customer-centric culture we strive to offer tailored solutions for every program. Our clients are at the centre of everything we do.

Speak to our
experts

Our Unique Position

  • World ADC 2014 Award – World leader in ADC conjugation services
  • Integrated service from preclinical development of conjugated ADC to sterile Fill/Finish
  • 98% GMP batch success rate
  • Global supplier for one of the only two marketed ADCs for past 4 years
  • Unparalleled manufacturing experience - 600 batches (300 GMP) for 130 different ADC candidates
  • Over 40 different toxin/toxin-linker systems
  • ADC Grangemouth Site – Successfully audited by US FDA, UK MHRA, ANVISA – Brazil, PMDA – Japan
  • World ADC 2014 Award – World leader in ADC conjugation services
  • 2015 CMO Leadership Awards – Four awards for quality, reliability and regulatory excellence
  • Partnership with Fujifilm, UK for antibody services

Other Offerings

Proof-of-Concept Preclinical Development Studies

Conjugation Process Development and Scale Up

Pre-clinical and Toxicology ADC Manufacture

ADC Clinical and Commercial Manufacturing

ADC Fill/Finish

Analytical Method Development Services

Bulk Drug Substance and Finished Product Release Testing

In vivo an Imaging services

Piramal offers a fast-track early stage development service for your ADC programmes. Whether you are selecting your candidate mAb, linker or toxin, we have a programme that will meet your needs. Tailored to perfection.

Piramal offers ADC process development and scale-up through Tox manufacture and into GMP manufacture. Our highly experienced team has been working on ADCs for over 10 years, working on over 130 different ADC candidates and over 40 different toxin/toxin-linker systems.

We have been providing pharmaceutical intermediate and API process development services for nearly three decades from our network of R&D and manufacturing facilities across the globe.

World-leading multi-product facility for clinical and commercial manufacturing of antibody drug conjugates (ADCs). Process development. characterisation, optimisation and scale-up expertise supporting successful GMP manufacturing.

Piramal offers aseptic filling of ADC drug product through our FDA-approved state-of-the-art manufacturing facility in Lexington, KY. Our facility is centred around mobile isolator technology, providing an ISO 5 environment during processing, as well as product containment for potent and cytotoxic products.

Piramal's highly experienced Analytical Development team covers a wide range of analytical methods from small molecule analysis through to cell killing assays and ELISA development. All your analytical development and testing requirements on a single site.

We have been providing pharmaceutical intermediate and API process development services for nearly three decades from our network of R&D and manufacturing facilities across the globe.

We have been providing pharmaceutical intermediate and API process development services for nearly three decades from our network of R&D and manufacturing facilities across the globe.

Great!